• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • Clinical Trial Listings
    • What are Clinical Trials?
    • Become a Clinical Trial Volunteer
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Market Research
    • Benchmark Reports
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
  • White Papers
  • Clinical Trial Listings
  • Advertise
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Parexel Cuts 2009 Guidance, Shares Fall 40%

Parexel Cuts 2009 Guidance, Shares Fall 40%

October 28, 2008
CenterWatch Staff

Waltham, Mass.-based contract research organization Parexel reduced its 2009 fiscal year guidance, and share prices plunged more than 40% to $8.05 in late morning trading.

Citing slower than expected sales in September and a negative impact from foreign exchange rates, the company lowered its full-year consolidated revenue guidance to $1.1 to $1.3 billion, down from $1.22 to $1.25.

“We anticipated a slowdown during the summer months, and then expected an acceleration of activity in September as has been typical in the past. Ultimately, however, sales performance for the quarter turned out to be short of target,” said Parexel chairman and CEO Josef H. von Rickenbach in a company statement.

Parexel reported service revenues of $263 million for the first quarter of fiscal year 2009, a 26.4% increase compared with the same period prior year, but net income for the quarter was down to $13.6 million from $13.9 million.

    Upcoming Events

    • 05Dec

      Thriving in Clinical Research – Overcoming Common Challenges as a Site: Part 3 – Site Resourcing

    • 14Apr

      MAGI 2024: The Clinical Research Conference

    Featured Products

    • Surviving an FDA GCP Inspection

      Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

    • Best Practices for Clinical Trial Site Management

      Best Practices for Clinical Trial Site Management

    Featured Stories

    • Jonathan Seltzer

      Thought Leadership: Remote Patient Monitoring Gives New View of Safety in Cardiac Clinical Trials

    • Quality_Compass-360x240.png

      Ask the Experts: Applying Quality by Design to Protocols

    • Obesity Treatment Patient

      Clinical Trials Need Greater Representation of Obese Patients, Experts Say

    • Modernize-360x240.png

      FDA IT Modernization Plan Prioritizes Data-Sharing, AI, Collaboration and More

    Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

    The information you need to adapt your monitoring plan to changing times.

    Learn More Here
    • About Us
    • Contact Us
    • Privacy Policy
    • Do Not Sell or Share My Data

    Footer Logo

    300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

    Phone 703.538.7600 – Toll free 888.838.5578

    Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing